Zentalis Grants Stock Options for 136,000 Shares to Four New Employees

By Public Technologies
  • Zentalis Pharmaceuticals granted non-qualified stock options covering 136,000 shares to four newly hired employees on November 2, 2026.
  • The options carry a 10-year term under the 2022 Employment Inducement Incentive Award Plan.
  • Vesting spans four years: 25% on the first anniversary of the vesting commencement date, with 75% vesting monthly over the next three years.
  • Each vesting installment requires continued service.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zentalis Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611021700PRIMZONEFULLFEED9868546) on November 02, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.